The benefits of adopting ePROMs for cancer patients – Manchester Cancer Research Centre
Manchester Cancer Research Centre shared a post on LinkedIn about a paper by Sally Wheelwright et al. published in Journal of Cancer Policy:
“Researchers from across the UK have proposed ePROMs to be embedded in the National Cancer Plan, currently collecting evidence.
Adoption of electronic Patient Recorded Outcome Measures (ePROMs) remains sporadic across English trusts despite recommendation by professional bodies, NICE guidelines and APPGs.
ePROMS have been extensively used at The Christie NHS Foundation Trust completing over 70,000 ePROMs since 2019, with feedback spotlighting improved communication and patient involvement.
The benefits of adopting ePROMs for cancer patients include better outcomes, improved physical function, and improved quality of life.
Read more in Journal of Cancer Policy.”
“Integrating ePROMs: A key opportunity for England’s National Cancer Plan”
Authors: Sally Wheelwright, Ollie Minton, Kate Absolom, Corinne Faivre-Finn, Lesley Fallowfield, Alexandra Gilbert, Duncan Gilbert, Alison Large, Thitikorn Nuamek, James Price, Tim Williams, Janelle Yorke, Valerie Shilling.
More posts featuring Manchester Cancer Research Centre.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023